Mechanistically, T cell factor-1 (TCF1) regulated the expression of EphB2 through promoter activation to form a positive Wnt/β-catenin feedback loop, thereby regulating cancer stemness and drug resistance. This evidence concerns the gene EPHB2 and cancer.